Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0RQO stock hub

LON/0RQO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RQOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RQO

In the news

Latest news · LON/0RQO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.6

P25 12.9P50 16.9P75 23.5

Trailing P/E81.3

P25 15.9P50 22.9P75 35.8

ROE22

P25 -54.2P50 2.1P75 13.7

ROIC46.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RQO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

SEK

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	160
Employees Change	12%
Employees Change Percent	9.16
Enterprise value	SEK 1.2B
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	SE0009858152
Last refreshed	2026-05-10
Market cap	SEK 1.2B
Price	SEK 229
Price currency	SEK
Rev Per Employee	604,349.33x
Sector	Healthcare
Sic	3842
Symbol	lon/0RQO
Website	https://www.bonesupport.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.23%
EV Earnings	78.94x
EV/EBIT	45.66x
EV/EBITDA	44.26x
EV/FCF	59.17x
EV/Sales	12.03x
FCF yield	1.64%
Forward P/E	42.61x
P/B ratio	16.03x
P/E ratio	81.33x
P/S ratio	12.39x
PE Ratio3 Y	107.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.34%
EBITDA Margin	26.51%
FCF margin	20.32%
Gross margin	92.48%
Gross Profit	SEK 89.4M
Gross Profit Growth	21.61%
Gross Profit Growth Q	13.85%
Gross Profit Growth3 Y	48.09%
Gross Profit Growth5 Y	47.16%
Net Income	SEK 14.7M
Net Income Growth	51.31%
Net Income Growth Q	411.94%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	20.94%
Profit Margin	15.23%
Profit Per Employee	SEK 92,063
Profitable Years	3
ROA	19.86
Roa5y	1.57
ROCE	33.86
ROE	22.04
Roe5y	9.56
ROIC	46.63
Roic5y	-26.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-23.74%
Cagr3y	31.4%
Cagr5y	25.66%
EPS Growth	50.66
EPS Growth Q	405.3
EPS Growth Quarters	1
EPS Growth Years	1
FCF Growth	162.51%
FCF Growth Q	60.76%
OCF Growth	161.56%
OCF Growth Q	60.7%
Revenue Growth	21.78x
Revenue Growth Q	14.28x
Revenue Growth Quarters	23x
Revenue Growth Years	7x
Revenue Growth3 Y	47.04x
Revenue Growth5 Y	46.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 1.21
Assets	SEK 89M
Cash	SEK 36.2M
Current Assets	SEK 70.9M
Current Liabilities	SEK 13.8M
Debt	SEK 1.1M
Debt EBITDA	SEK 0.04
Debt Equity	SEK 0.02
Debt FCF	SEK 0.06
Equity	SEK 74.7M
Interest Coverage	11.85
Liabilities	SEK 14.3M
Long Term Assets	SEK 18.2M
Long Term Liabilities	SEK 507,510
Net Cash	SEK 35.1M
Net Cash By Market Cap	SEK 2.93
Net Cash Growth	73.36%
Net Debt EBITDA	SEK -1.37
Net Debt Equity	SEK -0.47
Net Debt FCF	SEK -1.79
Tangible Book Value	SEK 73.5M
Tangible Book Value Per Share	SEK 1.12
WACC	7.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.13
Inventory Turnover	0.65
Net Working Capital	SEK 21.5M
Quick ratio	3.9
Working Capital	SEK 57.1M
Working Capital Turnover	SEK 0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-23.72%
200-day SMA	233.9
3Y total return	126.9%
50-day SMA	213.7
50-day SMA vs 200-day SMA	50under200
5Y total return	213.27%
All Time High	404.4
All Time High Change	-43.41%
All Time High Date	2025-01-08
All Time Low	12.06
All Time Low Change	1,797.53%
All Time Low Date	2018-05-21
ATR	9.54
Beta	0.48
Ch YTD	21.94
High	230.6
High52	345.8
High52 Date	2025-07-30
High52ch	-33.82%
Low	228
Low52	167.6
Low52 Date	2026-02-24
Low52ch	36.58%
Ma50ch	7.09%
Price vs 200-day SMA	-2.18%
RSI	51.36
RSI Monthly	48.77
RSI Weekly	52.06
Sharpe ratio	-0.54x
Sortino ratio	-0.68
Total Return	-0.12%
Tr YTD	21.94
Tr1m	3.83%
Tr1w	0.46%
Tr3m	34.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 25.5M
Operating Income Growth	120.6
Operating Income Growth Q	143.4
Operating margin	26.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,006,379%
Net Borrowing	-536,542.8
Shares Insiders	10.33%
Shares Institutions	44.38%
Shares Qo Q	-0%
Shares Yo Y	0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 17.2M
Average Volume	45,780.7x
Bv Per Share	1.13
CAPEX	SEK -209,205
Ch1m	3.83
Ch1w	0.46
Ch1y	-23.72
Ch3m	34.93
Ch3y	126.9
Ch5y	213.3
Ch6m	13.48
Change	-0.85%
Change From Open	0.19
Close	230.8
Days Gap	-1.04
Depreciation Amortization	168,201.9
Dollar Volume	537,091.3
Earnings Date	2026-04-22
EBIT	SEK 25.5M
EBITDA	SEK 25.6M
EPS	SEK 0.22
F Score	5
FCF	SEK 19.7M
FCF EV Yield	1.69x
Financing CF	-4,468,904
Fiscal Year End	December
Founded	1,999
Graham Number	30.06004
Graham Upside	-86.86
Income Tax	SEK 5.5M
Investing CF	-434,405
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Ma150	209.1
Ma150ch	9.43%
Ma20	240
Ma20ch	-4.64%
Net CF	14,970,221
Next Earnings Date	2026-07-16
Open	228.4
P FCF Ratio	60.95
P OCF Ratio	60.31
Position In Range	32.37
Ppne	1,642,102.9
Price Date	2026-05-08
Price EBITDA	SEK 46.73
Ptbv Ratio	16.29
Relative Volume	0.04x
Revenue	96,695,892x
SBC By Revenue	2.58x
Share Based Comp	2,491,443
Tax By Revenue	5.71x
Tax Rate	27.25%
Tr6m	13.48%
Volume	2,347
Z Score	56.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RQO pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RQO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RQO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.4%

Share of float held by funds and institutions

Insider ownership

+10.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0RQO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.4

Neutral momentum band

Price vs 200-day MA

-2.2%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

-0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RQO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RQO stock rating?

lon/0RQO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RQO analysis?

The full report lives at /stocks/lon/0RQO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RQO?

The latest report frames lon/0RQO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RQO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.